Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

InvestorSoup.com: CYCC's total revenues for third-quarter of 2009 decrease by 14%

Acupuncture may reduce joint pain and stiffness caused by routine breast cancer therapy

Acupuncture may reduce joint pain and stiffness caused by routine breast cancer therapy

Research suggests a potential means of circumventing drug resistance in breast cancer patients

Research suggests a potential means of circumventing drug resistance in breast cancer patients

FDA grants accelerated approval for GlaxoSmithKline's TYKERB

FDA grants accelerated approval for GlaxoSmithKline's TYKERB

CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging breast cancer therapies

CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging breast cancer therapies

Researchers present new data for diagnosis and management of beast cancer

Researchers present new data for diagnosis and management of beast cancer

Findings from three studies using bioTheranostics' breast cancer molecular test reported

Findings from three studies using bioTheranostics' breast cancer molecular test reported

Pfizer announces IES analysis of Aromasin in breast cancer recurrence

Pfizer announces IES analysis of Aromasin in breast cancer recurrence

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Pfizer to present study findings from its expanded breast cancer portfolio

Pfizer to present study findings from its expanded breast cancer portfolio

Group Health Research Institute to receive federal stimulus funds from ARRA

Group Health Research Institute to receive federal stimulus funds from ARRA

Pfizer Oncology to present early-stage research of investigational agents for cancer treatment

Pfizer Oncology to present early-stage research of investigational agents for cancer treatment

Low-dose estrogen effective for metastatic breast cancer

Low-dose estrogen effective for metastatic breast cancer

Pregabalin shows potential as treatment for hot flashes

Pregabalin shows potential as treatment for hot flashes

Scientists visualize the mechanism of synthesizing estrogen

Scientists visualize the mechanism of synthesizing estrogen

Fruits, vegetables and fiber may cut risk of breast cancer recurrence in women without hot flashes

Fruits, vegetables and fiber may cut risk of breast cancer recurrence in women without hot flashes

Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane

Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane

Postmenopausal patients being considered for tamoxifen therapy should be tested for CYP2D6 gene deficiency

Postmenopausal patients being considered for tamoxifen therapy should be tested for CYP2D6 gene deficiency

Femara shows reduced risk of death versus tamoxifen after breast cancer surgery

Femara shows reduced risk of death versus tamoxifen after breast cancer surgery